Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Margolis

Showing results (121-130 of 219) with videos related to

Pageof 22
Sort By:
Antiviral Research|September 8, 2015
Mixed effects of suberoylanilide hydroxamic acid (SAHA) on the host transcriptome and proteome and their implications for HIV reactivation from latencyCory H White, Harvey E Johnston, Bastiaan Moesker, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2024
Rapid viral suppression using integrase inhibitors during acute HIV-1 infectionMehri S McKellar, Jessica R Keys, Lindsey M Filiatreau, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2024
Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targetsSamuel L M Raines, Shane D Falcinelli, Jackson J Peterson, et al.
AIDS Research and Human Retroviruses|April 27, 2010
Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174Kimberly Smith, Lu Zheng, Ronald Bosch, et al.
The Journal of Infectious Diseases|August 22, 2023
Impact of Cannabis Use on Immune Cell Populations and the Viral Reservoir in People With HIV on Suppressive Antiretroviral TherapyShane D Falcinelli, Alicia D Cooper-Volkheimer, Lesia Semenova, et al.
Antimicrobial Agents and Chemotherapy|July 21, 2025
Correction for Raines et al., "Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets"Samuel L M Raines, Shane D Falcinelli, Jackson J Peterson, et al.
Genomics, Proteomics & Bioinformatics|June 20, 2024
Integrated Single-cell Multiomic Analysis of HIV Latency Reversal Reveals Novel Regulators of Viral ReactivationManickam Ashokkumar, Wenwen Mei, Jackson J Peterson, et al.
Cell Chemical Biology|December 14, 2019
Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical DegraderFrances Potjewyd, Anne-Marie W Turner, Joshua Beri, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 10, 2015
Characterizing the Switching Thresholds of Magnetophoretic TransistorsRoozbeh Abedini-Nassab, Daniel Y Joh, Melissa A Van Heest, et al.
Journal of Virology|January 7, 2014
HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT miceMaria Salgado, Michael D Swanson, Christopher W Pohlmeyer, et al.
Pageof 22

Showing results (121-130 of 219) with videos related to

Sort By:
Pageof 22
Antiviral Research|September 8, 2015
Mixed effects of suberoylanilide hydroxamic acid (SAHA) on the host transcriptome and proteome and their implications for HIV reactivation from latencyCory H White, Harvey E Johnston, Bastiaan Moesker, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2024
Rapid viral suppression using integrase inhibitors during acute HIV-1 infectionMehri S McKellar, Jessica R Keys, Lindsey M Filiatreau, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2024
Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targetsSamuel L M Raines, Shane D Falcinelli, Jackson J Peterson, et al.
AIDS Research and Human Retroviruses|April 27, 2010
Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174Kimberly Smith, Lu Zheng, Ronald Bosch, et al.
The Journal of Infectious Diseases|August 22, 2023
Impact of Cannabis Use on Immune Cell Populations and the Viral Reservoir in People With HIV on Suppressive Antiretroviral TherapyShane D Falcinelli, Alicia D Cooper-Volkheimer, Lesia Semenova, et al.
Antimicrobial Agents and Chemotherapy|July 21, 2025
Correction for Raines et al., "Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets"Samuel L M Raines, Shane D Falcinelli, Jackson J Peterson, et al.
Genomics, Proteomics & Bioinformatics|June 20, 2024
Integrated Single-cell Multiomic Analysis of HIV Latency Reversal Reveals Novel Regulators of Viral ReactivationManickam Ashokkumar, Wenwen Mei, Jackson J Peterson, et al.
Cell Chemical Biology|December 14, 2019
Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical DegraderFrances Potjewyd, Anne-Marie W Turner, Joshua Beri, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 10, 2015
Characterizing the Switching Thresholds of Magnetophoretic TransistorsRoozbeh Abedini-Nassab, Daniel Y Joh, Melissa A Van Heest, et al.
Journal of Virology|January 7, 2014
HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT miceMaria Salgado, Michael D Swanson, Christopher W Pohlmeyer, et al.
Pageof 22